Phase 2 Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years old, of any sex
- People whose kidneys and liver are working normally
- People who are willing to sign a consent form agreeing to take part in the study
- People who have been diagnosed with Ulcerative Colitis (a condition that causes inflammation in the large intestine) confirmed by a colonoscopy, lab tests, and tissue samples, following established medical guidelines
Who may not be able to join:
- People who have previously had an allergic or severe allergic reaction to silymarin (a natural substance found in milk thistle)
- People with significant kidney or liver problems
- People who do not wish to participate in the study
- Women who are pregnant, breastfeeding, or people who smoke
- People who are currently taking steroid medications (such as prednisolone) or biological therapy (specialist treatments that target the immune system)
- People who are currently taking any other antioxidant supplements or medications
- People who have other illnesses where damage caused by harmful molecules in the body plays a role, such as chronic liver disease or lung infections (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sahar M Ghobashy ElHaggar, Professor, Tanta University
Phone: +201140399467
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
2 points or more decrease in the Mayo score from baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.